Cargando…
Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases
There are over 50 lysosomal hydrolase deficiencies, many of which cause neurodegeneration, cognitive decline and death. In recent years, a number of broad innovative therapies have been proposed and investigated for lysosomal storage diseases (LSDs), such as enzyme replacement, substrate reduction,...
Autores principales: | Favret, Jacob M., Weinstock, Nadav I., Feltri, M. Laura, Shin, Daesung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174556/ https://www.ncbi.nlm.nih.gov/pubmed/32351971 http://dx.doi.org/10.3389/fmolb.2020.00057 |
Ejemplares similares
-
Human iPSC-Based Models for the Development of Therapeutics Targeting Neurodegenerative Lysosomal Storage Diseases
por: Luciani, Marco, et al.
Publicado: (2020) -
Modeling Lysosomal Storage Diseases in the Zebrafish
por: Zhang, T., et al.
Publicado: (2020) -
Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease
por: Weinstock, Nadav I., et al.
Publicado: (2020) -
Reproduction in Animal Models of Lysosomal Storage Diseases: A Scoping Review
por: Vuolo, Daniela, et al.
Publicado: (2021) -
CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges
por: Edelmann, Mariola J., et al.
Publicado: (2020)